North Korea vs Tonga: Immunization, Hib3 (% of children ages 12-23 months)
North Korea
99.0%
in 2024
Tonga
99.0%
in 2024
North Korea rank
1st
Tonga rank
1st
Immunization, Hib3 (% of children ages 12-23 months) over time
- North Korea
- Tonga
How they compare
North Korea currently reports 99.0% against 99.0% in Tonga, a difference of 0.0%.
Across all 13 years both countries report, Tonga has been ahead every year.
North Korea ranks 1st and Tonga ranks 1st of 191 countries.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Korea | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 87.6% | 97.6% | 10.0% | Tonga |
| 2020s | 98.6% | 99.0% | 0.4% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, North Korea or Tonga?
- North Korea, at 99.0% against 99.0% in Tonga as of 2024.
- What is the difference in immunization, hib3 between North Korea and Tonga?
- 0.0%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Tonga?
- 13 years are reported by both, from 2012 to 2024.
- How do North Korea and Tonga rank globally for immunization, hib3?
- North Korea ranks 1st and Tonga ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.